These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 29391779)

  • 1. Biological activity, quantitative structure-activity relationship analysis, and molecular docking of xanthone derivatives as anticancer drugs.
    Miladiyah I; Jumina J; Haryana SM; Mustofa M
    Drug Des Devel Ther; 2018; 12():149-158. PubMed ID: 29391779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. QSAR and docking studies on xanthone derivatives for anticancer activity targeting DNA topoisomerase IIα.
    Alam S; Khan F
    Drug Des Devel Ther; 2014; 8():183-95. PubMed ID: 24516330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative structure-activity relationship (QSAR) and molecular docking of xanthone derivatives as anti-tuberculosis agents.
    Yuanita E; Sudirman ; Dharmayani NKT; Ulfa M; Syahri J
    J Clin Tuberc Other Mycobact Dis; 2020 Dec; 21():100203. PubMed ID: 33294629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent cancer drug development with xanthone structures.
    Na Y
    J Pharm Pharmacol; 2009 Jun; 61(6):707-12. PubMed ID: 19505360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Xanthone Conjugated Amino Acids as Potential Anticancer and DNA Binding Agents: Molecular Docking, Cytotoxicity and SAR Studies.
    Rakesh KP; Darshini N; Manukumar HM; Vivek HK; Eissa MYH; Prasanna DS; Mallesha N
    Anticancer Agents Med Chem; 2018; 18(15):2169-2177. PubMed ID: 30179146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Xanthones for melanogenesis inhibition: Molecular docking and QSAR studies to understand their anti-tyrosinase activity.
    Rosa GP; Palmeira A; Resende DISP; Almeida IF; Kane-Pagès A; Barreto MC; Sousa E; Pinto MMM
    Bioorg Med Chem; 2021 Jan; 29():115873. PubMed ID: 33242700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular Docking, G-QSAR Studies, Synthesis and Anticancer Screening of Some New 2-Phenazinamines as Bcr-Abl Tyrosine Kinase Inhibitors.
    Kale MA; Sonwane GM
    Curr Drug Discov Technol; 2020; 17(2):213-224. PubMed ID: 30210004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Virtual screening, Docking, ADMET and System Pharmacology studies on Garcinia caged Xanthone derivatives for Anticancer activity.
    Alam S; Khan F
    Sci Rep; 2018 Apr; 8(1):5524. PubMed ID: 29615704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prenylated xanthones and benzophenones from the fruits of Garcinia bracteata and their potential antiproliferative and anti-inflammatory activities.
    Xue Q; Chen Y; Yin H; Teng H; Qin R; Liu H; Li Q; Mei Z; Yang G
    Bioorg Chem; 2020 Nov; 104():104339. PubMed ID: 33142411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of xanthone derivatives based on α-mangostin and their biological evaluation for anti-cancer agents.
    Fei X; Jo M; Lee B; Han SB; Lee K; Jung JK; Seo SY; Kwak YS
    Bioorg Med Chem Lett; 2014 May; 24(9):2062-5. PubMed ID: 24717154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of Novel Xanthone Analogues and Their Growth Inhibitory Activity Against Human Lung Cancer A549 Cells.
    Wu J; Dai J; Zhang Y; Wang J; Huang L; Ding H; Li T; Zhang Y; Mao J; Yu S
    Drug Des Devel Ther; 2019; 13():4239-4246. PubMed ID: 31853172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytotoxic and Anti-Inflammatory Activities of Dihydroisocoumarin and Xanthone Derivatives from
    Sukandar ER; Kaennakam S; Raab P; Nöst X; Rassamee K; Bauer R; Siripong P; Ersam T; Tip-Pyang S; Chavasiri W
    Molecules; 2021 Nov; 26(21):. PubMed ID: 34771035
    [No Abstract]   [Full Text] [Related]  

  • 13. Design, synthesis and biological evaluation of novel 1-hydroxyl-3-aminoalkoxy xanthone derivatives as potent anticancer agents.
    Yang ZM; Huang J; Qin JK; Dai ZK; Lan WL; Su GF; Tang H; Yang F
    Eur J Med Chem; 2014 Oct; 85():487-97. PubMed ID: 25113877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, inhibitory activities, and QSAR study of xanthone derivatives as alpha-glucosidase inhibitors.
    Liu Y; Ke Z; Cui J; Chen WH; Ma L; Wang B
    Bioorg Med Chem; 2008 Aug; 16(15):7185-92. PubMed ID: 18632275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Docking-assisted 3D-QSAR studies on xanthones as α-glucosidase inhibitors.
    Zheng X; Zhou S; Zhang C; Wu D; Luo HB; Wu Y
    J Mol Model; 2017 Aug; 23(9):272. PubMed ID: 28861624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytotoxic and α-Glucosidase Inhibitory Xanthones from Garcinia mckeaniana Leaves and Molecular Docking Study.
    Thi Thu HN; Minh QP; Van CP; Van TN; Van KP; Thanh TN; Le Thi Tu A; Litaudon M; The SN
    Chem Biodivers; 2021 Nov; 18(11):e2100396. PubMed ID: 34529335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel benzothiazole-based dual VEGFR-2/EGFR inhibitors targeting breast and liver cancers: Synthesis, cytotoxic activity, QSAR and molecular docking studies.
    Abd El-Meguid EA; Naglah AM; Moustafa GO; Awad HM; El Kerdawy AM
    Bioorg Med Chem Lett; 2022 Feb; 58():128529. PubMed ID: 35007724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytotoxic activity and DNA-binding properties of xanthone derivatives.
    Shen R; Wang P; Tang N
    J Fluoresc; 2010 Nov; 20(6):1287-97. PubMed ID: 20532595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of New Synthetic Xanthones on the Proliferation and Migration Potential of Cancer Cell Lines In Vitro.
    Szkaradek N; Sypniewski D; Żelaszczyk D; Gałka S; Borzdziłowska P; Marona H; Bednarek I
    Anticancer Agents Med Chem; 2019; 19(16):1949-1965. PubMed ID: 30950354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of New Pyrazolopyridine, Furopyridine, and Pyridine Derivatives as CDK2 Inhibitors: Design, Synthesis, Docking Studies, and Anti-Proliferative Activity.
    Abdel-Rahman AA; Shaban AKF; Nassar IF; El-Kady DS; Ismail NSM; Mahmoud SF; Awad HM; El-Sayed WA
    Molecules; 2021 Jun; 26(13):. PubMed ID: 34206976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.